{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:47:23Z","timestamp":1793656043172,"version":"4.5.1"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T00:00:00Z","timestamp":1669680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Neurosci."],"abstract":"<jats:p>Despite the knowledge that mutation, multiplication, and anomalous function of <jats:italic>\u03b1<\/jats:italic>-synuclein cause progressive transformation of <jats:italic>\u03b1<\/jats:italic>-synuclein monomers into toxic amyloid fibrils in neurodegenerative diseases, the understanding of canonical signaling, interaction network molecules, biological functions, and role of <jats:italic>\u03b1<\/jats:italic>-synuclein remains ambiguous. The evolution of artificial intelligence and Bioinformatics tools have enabled us to analyze a vast pool of data to draw meaningful conclusions about the events occurring in complex biological systems. We have taken the advantage of such a Bioinformatics tool, ingenuity pathway analysis (IPA) to decipher the signaling pathways, interactome, biological functions, and role of <jats:italic>\u03b1<\/jats:italic>-synuclein. IPA of the <jats:italic>\u03b1<\/jats:italic>-synuclein NCBI gene dataset revealed neuroinflammation, Huntington\u2019s disease, TREM1, phagosome maturation, and sirtuin signaling as the key canonical signaling pathways. IPA further revealed Parkinson\u2019s disease (PD), sumoylation, and SNARE signaling pathways specific to the toxicity of <jats:italic>\u03b1<\/jats:italic>-synuclein. A frequency distribution analysis of <jats:italic>\u03b1<\/jats:italic>-synuclein-associated genes from the NCBI dataset that appeared in the predicted canonical pathways revealed that NFKB1 was the most populated gene across the predicted pathways followed by FOS, PRKCD, TNF, GSK3B, CDC42, IL6, MTOR, PLCB1, and IL1B. Overlapping of the predicted top-five canonical signaling pathways and the <jats:italic>\u03b1<\/jats:italic>-synuclein NCBI gene dataset divulged that neuroinflammation signaling was the most overlapped pathway, while NFKB1, TNF, and CASP1 were the most shared molecules among the pathways. The major diseases associated with <jats:italic>\u03b1<\/jats:italic>-synuclein were predicted to be neurological diseases, organismal injury and abnormalities, skeletal and muscular disorders, psychological disorders, and hereditary disorders. The molecule activity predictor (MAP) analysis of the principal interaction network of <jats:italic>\u03b1<\/jats:italic>-synuclein gene SNCA revealed that SNCA directly interacts with APP, CLU, and NEDD4, whereas it indirectly communicates with CALCA and SOD1. Besides, IPA also predicted amyloid plaque forming APP, cytokines\/inflammatory mediators IL1B, TNF, MIF, PTGS2, TP53, and CCL2, and kinases of MAPK family Mek, ERK, and P38 MAPK as the top upstream regulators of <jats:italic>\u03b1<\/jats:italic>-synuclein signaling cascades. Taken together, the first IPA analysis of <jats:italic>\u03b1<\/jats:italic>-synuclein predicted PD as the key toxicity pathway, neurodegeneration as the major pathological outcome, and inflammatory mediators as the critical interacting partners of <jats:italic>\u03b1<\/jats:italic>-synuclein.<\/jats:p>","DOI":"10.3389\/fnmol.2022.1029682","type":"journal-article","created":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T04:59:53Z","timestamp":1669697993000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Ingenuity pathway analysis of \u03b1-synuclein predicts potential signaling pathways, network molecules, biological functions, and its role in neurological diseases"],"prefix":"10.3389","volume":"15","author":[{"given":"Sharad Kumar","family":"Suthar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Yoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,29]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"110090","DOI":"10.1016\/j.celrep.2021.110090","article-title":"Alpha synuclein, the culprit in Parkinson disease, is required for normal immune function","volume":"38","author":"Alam","year":"2022","journal-title":"Cell Rep."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"29739","DOI":"10.1074\/jbc.M600933200","article-title":"Phosphorylation of Ser-129 is the dominant pathological modification of \u03b1-synuclein in familial and sporadic Lewy body disease","volume":"281","author":"Anderson","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s004010050917","article-title":"NACP\/\u03b1-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy","volume":"96","author":"Arima","year":"1998","journal-title":"Acta Neuropathol."},{"key":"ref4","first-page":"879","article-title":"Aggregation of \u03b1-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies","volume":"152","author":"Baba","year":"1998","journal-title":"Am. J. Pathol."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"E4274","DOI":"10.1073\/pnas.1416598111","article-title":"\u03b1-Synuclein assembles into higher-order multimers upon membrane binding to promote SNARE complex formation","volume":"111","author":"Burr\u00e9","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1126\/science.1195227","article-title":"\u03b1-Synuclein promotes SNARE-complex assembly in vivo and in vitro","volume":"329","author":"Burr\u00e9","year":"2010","journal-title":"Science"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/s0022-2836(03)00520-5","article-title":"A structural and functional role for 11-mer repeats in \u03b1-synuclein and other exchangeable lipid binding proteins","volume":"329","author":"Bussell","year":"2003","journal-title":"J. Mol. Biol."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1110\/ps.041255905","article-title":"Helix periodicity, topology, and dynamics of membrane-associated \u03b1-synuclein","volume":"14","author":"Bussell","year":"2005","journal-title":"Protein Sci."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"13107","DOI":"10.1074\/jbc.M110.100420","article-title":"Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-\u03b2, and tau","volume":"285","author":"Caccamo","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.cell.2005.09.028","article-title":"\u03b1-Synuclein cooperates with CSP\u03b1 in preventing neurodegeneration","volume":"123","author":"Chandra","year":"2005","journal-title":"Cells"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1021\/bi991447r","article-title":"Fibrils formed in vitro from \u03b1-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid","volume":"39","author":"Conway","year":"2000","journal-title":"Biochemistry"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/cdd.2014.179","article-title":"GSK-3\u03b2 dysregulation contributes to Parkinson's-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and \u03b1-synuclein","volume":"22","author":"Credle","year":"2015","journal-title":"Cell Death Differ."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"9443","DOI":"10.1074\/jbc.273.16.9443","article-title":"Stabilization of \u03b1-synuclein secondary structure upon binding to synthetic membranes","volume":"273","author":"Davidson","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e2000374","DOI":"10.1371\/journal.pbio.2000374","article-title":"The mechanism of sirtuin 2-mediated exacerbation of \u03b1-synuclein toxicity in models of Parkinson disease","volume":"15","author":"de Oliveira","year":"2017","journal-title":"PLoS Biol."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/glia.23920","article-title":"Extracellular clusterin limits the uptake of \u03b1-synuclein fibrils by murine and human astrocytes","volume":"69","author":"Filippini","year":"2021","journal-title":"Glia"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ncb748","article-title":"\u03b1-Synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"Fujiwara","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1074\/jbc.M008919200","article-title":"A hydrophobic stretch of 12 amino acid residues in the middle of \u03b1-synuclein is essential for filament assembly","volume":"276","author":"Giasson","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13024-015-0062-3","article-title":"\u03b1-Synuclein interacts with SOD1 and promotes its oligomerization","volume":"10","author":"Helferich","year":"2015","journal-title":"Mol. Neurodegener."},{"key":"ref19","year":"2021"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/00005072-199804000-00005","article-title":"Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain \u03b1-synuclein immunoreactivity","volume":"57","author":"Irizarry","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrn3406","article-title":"The many faces of \u03b1-synuclein: from structure and toxicity to therapeutic target","volume":"14","author":"Lashuel","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"108017","DOI":"10.1016\/j.neuropharm.2020.108017","article-title":"Characterization of the effects of calcitonin gene-related peptide receptor antagonist for Alzheimer\u2019s disease","volume":"168","author":"Na","year":"2020","journal-title":"Neuropharmacology"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1111\/j.1432-1033.1993.tb18337.x","article-title":"A new brain-specific 14-kDa protein is a phosphoprotein. Its complete amino acid sequence and evidence for phosphorylation","volume":"217","author":"Nakajo","year":"1993","journal-title":"Eur. J. Biochem."},{"key":"ref24","year":"2021"},{"key":"ref25","year":"2022"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41531-021-00203-9","article-title":"Alpha-synuclein research: defining strategic moves in the battle against Parkinson\u2019s disease","volume":"7","author":"Oliveira","year":"2021","journal-title":"NPJ Parkinsons Dis."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1126\/science.1143780","article-title":"Sirtuin 2 inhibitors rescue \u03b1-synuclein-mediated toxicity in models of Parkinson's disease","volume":"317","author":"Outeiro","year":"2007","journal-title":"Science"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"e1209","DOI":"10.1038\/cddis.2014.175","article-title":"Metformin lowers Ser-129 phosphorylated \u03b1-synuclein levels via mTOR-dependent protein phosphatase 2A activation","volume":"5","author":"P\u00e9rez-Revuelta","year":"2014","journal-title":"Cell Death Dis."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"e0171925","DOI":"10.1371\/journal.pone.0171925","article-title":"\u03b1-Synuclein increases \u03b2-amyloid secretion by promoting \u03b2\u2212\/\u03b3-secretase processing of APP","volume":"12","author":"Roberts","year":"2017","journal-title":"PLoS One"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"661505","DOI":"10.3389\/fnagi.2021.661505","article-title":"PKC delta activation promotes endoplasmic reticulum stress (ERS) and NLR family pyrin domain-containing 3 (NLRP3) inflammasome activation subsequent to asynuclein-induced microglial activation: involvement of thioredoxin-interacting protein (TXNIP)\/thioredoxin (Trx) redoxisome pathway","volume":"13","author":"Samidurai","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/j.neuroscience.2008.02.049","article-title":"Protein array analysis of oligomerization-induced changes in alpha-synuclein protein-protein interactions points to an interference with Cdc42 effector proteins","volume":"154","author":"Schnack","year":"2008","journal-title":"Neuroscience"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"4897","DOI":"10.1073\/pnas.97.9.4897","article-title":"Fiber diffraction of synthetic \u03b1-synuclein filaments shows amyloid-like cross-\u03b2 conformation","volume":"97","author":"Serpell","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1126\/science.1060627","article-title":"Ubiquitination of a new form of \u03b1-synuclein by parkin from human brain: implications for Parkinson's disease","volume":"293","author":"Shimura","year":"2001","journal-title":"Science"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/s0304-3940(98)00504-7","article-title":"Filamentous \u03b1-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies","volume":"251","author":"Spillantini","year":"1998","journal-title":"Neurosci. Lett."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","article-title":"\u03b1-Synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"667947","DOI":"10.3389\/fmolb.2021.667947","article-title":"Bioinformatic analyses of canonical pathways of TSPOAP1 and its roles in human diseases","volume":"8","author":"Suthar","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"ref37","first-page":"367","article-title":"Abnormal accumulation of NACP\/\u03b1-synuclein in neurodegenerative disorders","volume":"152","author":"Takeda","year":"1998","journal-title":"Am. J. Pathol."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"17004","DOI":"10.1073\/pnas.1109356108","article-title":"Ubiquitin ligase Nedd4 promotes \u03b1-synuclein degradation by the endosomal-lysosomal pathway","volume":"108","author":"Tofaris","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1001\/archneur.55.2.151","article-title":"Aggregation of neurofilament and \u03b1-synuclein proteins in Lewy bodies: implications for the pathogenesis of Parkinson disease and Lewy body dementia","volume":"55","author":"Trojanowski","year":"1998","journal-title":"Arch. Neurol."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/ana.410440324","article-title":"Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble \u03b1-synuclein","volume":"44","author":"Tu","year":"1998","journal-title":"Ann. Neurol."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nsmb.3194","article-title":"Solid-state NMR structure of a pathogenic fibril of full-length human \u03b1-synuclein","volume":"23","author":"Tuttle","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"11282","DOI":"10.1073\/pnas.90.23.11282","article-title":"Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease","volume":"90","author":"U\u00e9da","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.jmb.2009.03.021","article-title":"The first N-terminal amino acids of \u03b1-synuclein are essential for \u03b1-helical structure formation in vitro and membrane binding in yeast","volume":"389","author":"Vamvaca","year":"2009","journal-title":"J. Mol. Biol."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s004010050918","article-title":"Accumulation of \u03b1-synuclein\/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy","volume":"96","author":"Wakabayashi","year":"1998","journal-title":"Acta Neuropathol."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/s0304-3940(97)00891-4","article-title":"NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease","volume":"239","author":"Wakabayashi","year":"1997","journal-title":"Neurosci. Lett."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.bbadis.2008.09.013","article-title":"Molecular mechanisms of \u03b1-synuclein neurodegeneration","volume":"1792","author":"Waxman","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"13709","DOI":"10.1021\/bi961799n","article-title":"NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded","volume":"35","author":"Weinreb","year":"1996","journal-title":"Biochemistry"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.nbd.2014.05.031","article-title":"Lysine residues at the first and second KTKEGV repeats mediate \u03b1-synuclein binding to membrane phospholipids","volume":"70","author":"Zarbiv","year":"2014","journal-title":"Neurobiol. Dis."}],"container-title":["Frontiers in Molecular Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnmol.2022.1029682\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T05:00:03Z","timestamp":1669698003000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnmol.2022.1029682\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,29]]},"references-count":48,"alternative-id":["10.3389\/fnmol.2022.1029682"],"URL":"https:\/\/doi.org\/10.3389\/fnmol.2022.1029682","relation":{},"ISSN":["1662-5099"],"issn-type":[{"value":"1662-5099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,29]]},"article-number":"1029682"}}